Risultati per: Rosacea: gli strumenti per conoscerla e gestirla

This cohort study investigates whether calcitonin gene-related peptide inhibition is associated with reduced rates of developing acne or rosacea in patients who experience migraines.

Lo psichiatra, “ma la vacanza non sia un banco di prova delle proprie paure”

This nonrandomized controlled trial analyzes the efficacy and safety of erenumab, an anti–calcitonin gene-related peptide receptor monoclonal antibody, for rosacea-associated erythema and flushing.

This consensus statement uses the Delphi process to develop a core domain set for rosacea clinical trials and practice.

While many treatments are available for papules and pustules of rosacea, few are available for erythema and flushing. The 2019 Global Rosacea Consensus Panel recommends general skincare, β-blockers (eg, propranolol and carvedilol), and α-adrenergic agents (eg, brimonidine and oxymetazoline) for flushing and vascular lasers for persistent erythema. Because these treatments may not always be effective or tolerated, there remains an unmet need for additional options that can address symptoms of flushing and erythema in rosacea.

Il racconto delle esperienze dei pazienti e l’Sos degli esperti

Per sensibilizzare verso questa malattia rara, in Italia 12mila pazienti

Prosegue l’impegno della Società Italiana di Medicina Generale e delle Cure Primarie con la Società Italiana di Malattie Infettive e Tropicali nella formazione in ambito infettivologico. Attenzione per HIV ed Epatiti: troppe diagnosi tardive, “sommerso” da far emergere e rapido accesso ai trattamenti sono le lacune che il medico di famiglia può aiutare a colmare

This systematic review assesses inclusion of patient-reported outcome measures in randomized clinical trials on acne and rosacea treatments and the use of such measures as a primary outcome.

This systematic review and meta-analysis of 39 studies assesses the frequency of the 4 major subtypes in more than 9000 patients with rosacea.